Home
World Journal of Biology Pharmacy and Health Sciences
ISSN Approved | International, Peer reviewed, Referred, Open access Journal

Main navigation

  • Home
    • Journal Information
    • Abstracting and Indexing
    • Editorial Board Members
    • Reviewer Panel
    • Journal Policies
    • WJBPHS CrossMark Policy
    • Publication Ethics
    • Current Issue
    • Issue in Progress
    • Past Issues
    • Instructions for Authors
    • Article processing fee
    • Track Manuscript Status
    • Get Publication Certificate
    • Become a Reviewer panel member
    • Join as Editorial Board Member
  • Contact us
  • Downloads

ISSN Approved Journal | | IMPACT FACTOR 8.16 | | eISSN: 2582-5542 | |  Free Crossref DOI 

Fast Publication within 2 days | | Low Article Processing Charges | | Peer Reviewed and Referred Journal

Research and review articles are invited for publication in September 2026 (Volume 27, Issue 3) Submit Paper

Designing HIPAA-conformant agentic AI architectures on cloud infrastructure on clinical decision support systems

Breadcrumb

  • Home
  • Designing HIPAA-conformant agentic AI architectures on cloud infrastructure on clinical decision support systems

Arvind Telharkar *

Engineering Lead at Amazon.

Review Article

World Journal of Biology Pharmacy and Health Sciences, 2026, 26(03), 166-178

Article DOI: 10.30574/wjbphs.2026.26.3.0346

DOI url: https://doi.org/10.30574/wjbphs.2026.26.3.0346

Received on 02 May 2026; revised on 06 June 2026; accepted on 09 June 2026

The historical trend of integrating agentic artificial intelligence into clinical decision support systems would represent a paradigm shift of passive and recommendation-based decision support tools to autonomous and goal-oriented workflows capable of dynamic reasoning and action. But the autonomous nature of these agents, as characterized by an iterative process of perception, planning, and use of tools, directly challenges the underlying conditions of the Health Insurance Portability and Accountability Act especially with respect to granular access control, overall auditability, and accountability. Current clinical decision support systems based on clouds have no native constructs to regulate behavior of autonomous agents and hence there is a critical gap between the practical utility of agentic artificial intelligence and the regulatory imperative of HIPAA compliance. The given gap is filled in this paper, as it proposed a new four-part architectural structure that is intended to be used in cloud infrastructure. It includes policy-as-code and granular, dynamic authorization, encrypted episodic memory and patient-specific state retention, immutable and digitally signed action-log and verifiable audit trails, and a supervisory agent to enforce policy in real-time, refresh consent, and identify anomalies. Our reference implementation on a vendor-agnostic cloud stack based on Kubernetes, Dapr, and Open Policy Agent exemplifies a compliant patient-to-clinician data flow. The architecture supports fundamental HIPAA services such as a break-glass access service and a patient consent revocation service thus providing a secure, auditable and accountable basis to deploy autonomous agentic systems in regulated clinical settings.

Agentic AI; HIPAA Compliance; Clinical Decision Support Systems; Cloud Architecture; Autonomous Agents; Healthcare Data Privacy

https://wjbphs.com/sites/default/files/fulltext_pdf/WJBPHS-2026-0346.pdf

Get Your e Certificate of Publication using below link

Download Certificate

Preview Article PDF

Arvind Telharkar. Designing HIPAA-conformant agentic AI architectures on cloud infrastructure on clinical decision support systems. World Journal of Biology Pharmacy and Health Sciences, 2026, 26(03), 166-178. Article DOI: https://doi.org/10.30574/wjbphs.2026.26.3.0346

Get Certificates

Get Publication Certificate

Download LoA

Check Corssref DOI details

Issue details

Issue Cover Page

Editorial Board

Table of content


Copyright © Author(s). All rights reserved. This article is published under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits use, sharing, adaptation, distribution, and reproduction in any medium or format, as long as appropriate credit is given to the original author(s) and source, a link to the license is provided, and any changes made are indicated.


Copyright © 2026 World Journal of Biology Pharmacy and Health Sciences (WJBPHS) - All rights reserved

Developed & Designed by VS Infosolution